Trial Condition(s):

Multiple Sclerosis

Noninterventional study assessing cognitive function and physical activity in people with multiple sclerosis (CogniPlus)

Bayer Identifier:

16036

ClinicalTrials.gov Identifier:

NCT01491100

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.

Inclusion Criteria
-  Patients with Relapsing Remitting Multiple Sclerosis
(RRMS), and treated with Betaferon, with the decision for treatment made at the discretion of the attending physician, documented with a prescription of Betaferon by the physician
 -  EDSS 0 - 6
 -  Written informed consent
Exclusion Criteria
-  Patients who do not meet the local indication criteria for Betaferon treatment. 
 -  Contraindications listed in the local SmPCs have to be considered.
 -  Patients with a history of severe head trauma.
 -  Patients with alcohol and/or drug abuse.
 -  Patients with mental retardation.
 -  Patients with learning disability.

Trial Summary

Enrollment Goal
1085
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 
Locations

Investigative Site

Many Locations, Albania

Status
Completed
 
Locations

Investigative Site

Many Locations, France

Status
Completed
 
Locations

Investigative Site

Many Locations, Netherlands

Status
Completed
 
Locations

Investigative Site

Many Locations, Czech Republic

Status
Completed
 
Locations

Investigative Site

Many Locations, Israel

Status
Completed
 
Locations

Investigative Site

Many Locations, Portugal

Status
Completed
 
Locations

Investigative Site

Many Locations, Argentina

Status
Completed
 
Locations

Investigative Site

Many Locations, Hungary

Status
Completed
 
Locations

Investigative Site

Many Locations, Greece

Status
Completed
 
Locations

Investigative Site

Many Locations, Egypt

Status
Completed
 
Locations

Investigative Site

Many Locations, Kazakhstan

Status
Completed
 
Locations

Investigative Site

Many Locations, Saudi Arabia

Status
Completed
 
Locations

Investigative Site

Many Locations, Tunisia

Status
Completed
 
Locations

Investigative Site

Many Locations, Belgium

Status
Completed
 
Locations

Investigative Site

Many Locations, Turkey

Status
Completed
 
Locations

Investigative Site

Many Locations, Algeria

Status
Completed
 

Trial Design